AfriSMC was established by ScienceAfrica and Partners in September 2020 in Nairobi, Kenya, to improve the credibility of media reporting of emerging scientific issues, such as the Coronavirus pandemic.
Prof. Walter Jaoko’s responses to media queries on the new Omicron virus during an AfriSMC press briefing on What Scientists know about the new Covid-19 variant. Prof Jaoko is the Director KAVI-Institute of Clinical Research, University of Nairobi
Studies have shown that COVID-19 vaccines boost immunity, Prof. Abonyo explains whether they could also improve surfactant levels in the lungs:
Research shows that about 5% of patients with COVID-19, and 20% of those hospitalized, experience severe symptoms necessitating intensive care. Dr. Wekesa explains more on these complications.
AfriSMC was established by ScienceAfrica and Partners in September 2020 in Nairobi, Kenya, through a small grant from Cornell Alliance for Science principally to work with journalists and scientists on the continent to improve the credibility of media reporting of emerging scientific issues, such as the Coronavirus pandemic
AfriSMC was established by ScienceAfrica and Partners in September 2020 in Nairobi, Kenya, through a small grant from Cornell Alliance for Science principally to work with journalists and scientists on the continent to improve the credibility of media reporting of emerging scientific issues, such as the Coronavirus pandemic
